[Evaluation of autonomic dysfunction by novel methods].
The autonomic nervous system innervates every organ in the body. Since autonomic disturbances affect patient survival, an understanding and recognition of these disturbances are important. We adopted several new methods to evaluate autonomic function accurately. 123I-metaiodobenzylguanidine scintigraphy can assess the cardiac autonomic function even in the presence of cardiac arrhythmia. Laser-Doppler flowmetry, ultrasonographic study in the vessels and near-infrared spectrophotoscopy techniques serve as useful markers for screening the dysfunction of vasomotor neurons and blood circulation. Electrogastrography and the circadian rhythms of protein C secretion could be markers of the visceromotor nerves in the abdomen. Electrogastrography is a particularly useful tool for reflecting on functional changes in gastrointestinal motility. The evaluation of anemia could be a marker of autonomic dysfunction in the kidney and bone marrow in patients with familial amyloidotic polyneuropathy, pandysautonomia, and multiple system atrophy. Normocytic and normochromic anemia correlated with the severity of autonomic dysfunction were shown in these patients. We also evaluated the dysfunction of the neuroendocrine system and sudomotor neuron using our new autonomic function tests. The glucose-tolerance test could become one of the most useful clinical tools for detecting autonomic dysfunction in the endocrine system. Microhydrography and thermography could be useful tools for diagnosing the lesion site of dyshidrosis. Moreover, it is clinically important to check the systemic circulation and autonomic function in patients treated with sildenafil citrate and organ transplantation to save their lives. Our new autonomic function tests, such as laser-Doppler flowmetry and 123I-metaiodobenzylguanidine scintigraphy, are crucial tools in supplying the best symptomatic treatment for such patients.
Ando
Yukio
Y
Department of Diagnostic Medicine, Graduate School of Medical Sciences, Kumamoto University.
Obayashi
Konen
K
D019797:3-Iodobenzylguanidine; D001342:Autonomic Nervous System Diseases / Q000175:diagnosis* / Q000503:physiopathology; D015415:Biomarkers / Q000032:analysis; D003943:Diagnostic Techniques, Neurological; D004576:Electromyography; D006801:Humans; D007457:Iodine Radioisotopes; D017078:Laser-Doppler Flowmetry; D009490:Neurosecretory Systems / Q000503:physiopathology; D011486:Protein C / Q000032:analysis; D011877:Radionuclide Imaging / Q000379:methods; D019275:Radiopharmaceuticals; D019265:Spectroscopy, Near-Infrared; D014666:Vasomotor System / Q000503:physiopathology
D015415:Biomarkers; D007457:Iodine Radioisotopes; D011486:Protein C; D019275:Radiopharmaceuticals; D019797:3-Iodobenzylguanidine